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PATIENT MONITORING: INTRODUCTION
Improved health care for all members of our society is a major national
goal. A combination of a steadily increasing population, rapidly
rising medical costs and acute manpower shortages in the biomedical
sciences has resulted in a critical situation. In addition to the need
for a superior system of health care delivery, there are requirements
for the development of more adequate techniques and equipment for the
prevention, diagnosis and treatment of disease.
Our most well known health indices are life expectancy and infant
mortality. Life expectancy is an expression of the dangers imposed
on man by all fatal illnesses throughout an entire life span. Infant
mortality is a sensitive indicator of the effectiveness of the health care
delivery system. These two indices impose limitations because they
do not provide a measure of the state of health or non-fatal illness the
population undergoes. However, they do provide us with a guideline
for examining the effects of health care.
Over the past half century, life expectancy has gradually increased
and the infant mortality rate has decreased in the United States. How-
ever, during the past 20 years, life expectancy and infant mortality
have remained almost stable in the United States, forcing us to fall
behind many foreign countries. In addition, total expenditures for
medical care have increased over 130% during the past decade to $63. 5
billion in 1969. This increase in medical spending has taken place in
an environment of spiraling hospital costs and a growing shortage of
trained medical personnel.
One of the main causes for increased spending has been the increase
in hospitalization. In 1959 there was a total of 168 million patient days,
and in 1969 the yearly total was 200 million. By 1979, patient days
are expected to increase by approximately 60%. With the large rise in
demand for hospital services and with medical procedures becoming
more extensive and complex, a greater number of hospital personnel
at a higher unit cost will be required. While the cost of living index
has increased by 25% between 1959 and 1969, daily hospital service
charges increased by 160%. Hospital personnel costs are a
major cause of this dramatic rise. Not only have labor costs increased
from 57% of the total cost in 1947 to 66% in 1966, but the number of
hospital personnel per 100 patients has increased from 208 in 1959 to
285 in 1969. It is expected that in the 70's increased expenditures
on biomedical electronic equipment will relieve hospital personnel of
the more routine tasks and will provide more accurate information on
a rapid basis.
Biomedical electronic equipment sales have increased from 0.9% of the
health care spending in 1959 to 1. 3% in 1969. The equipment can be
divided into five categories: diagnostic, therapeutic, patient monitoring,
electronic data processing, and laboratory equipment. Of these, patient
monitoring is the second fastest growing (data processing is first) and
in 1969 accounted for 2.5% of the total sales.
Patient monitoring involves the continuous (or frequent, relative to the
period of time required for significant change) monitoring of human
physiological functions. Monitoring is used in intensive care units,
during surgery, in post-operative recovery rooms and even during
clinical screening. Although monitoring equipment will never replace
the physician's diagnostic capabilities, it does assist him in making
a rapid diagnosis by alerting him to a critical situation. Patient
monitoring equipment can quickly provide reliable patient information
that normally would be difficult to obtain.
The critically ill patient has a much better chance of survival in an
environment where there is continuous care and surveillance. The
more seriously ill a patient is, the less deterioration of condition
he can tolerate and the sooner corrective action must be taken. Con-
sequently, continuous monitoring is of vital importance: an impossible
task •with the use of only nursing staff. Equipment which can automati-
cally monitor a patient and alert a nurse or physician in case of emer-
gency is urgently needed. Although the number of hospitals which
monitor patients is rapidly growing, there is still a demand for im-
proved and more comprehensive equipment.
Specific requirements for patient monitoring equipment include the
need to determine cardiac output, atherosclerotic disorders, precise
intracardiac blood pressure, the effect of exercise on the cardio-
pulmonary system, and respiratory gas analysis. Some of these require-
ments result in the need for extensive improvements in existing equip-
ment. Other requirements imply that new and innovative equipment
must be developed. These improvements and developments may have
far-reaching effects on the quality of health care delivered to all patients.
Cardiovascular monitoring equipment has dominated, and will continue
to dominate, patient monitoring sales (see figure on next page) due to
the fact that continuou^monitoring of patients with severe heart trouble
can save many lives. Diseases of the cardiovascular system are a
primary cause of death in the United States. For example, it has been
generally accepted that if ventricular fibrillation can be detected within
1 to 3 minutes after its onset, at least one-third of the patients afflicted
can be saved. Such monitoring can only be accomplished by cardio-
vascular electronic equipment.
NASA is involved in a great deal of innovative and original research
and development work. Although this involves many branches of
science and engineering, one of the major goals is to understand the
effect JD| the space environment on biological systems -- human systems in
particular. This goal results in numerous requirements for under-
standing human physiological functions under normal and stressed
conditions and for monitoring and analyzing the resulting functions.
Fulfillment of these requirements has resulted in many benefits to
medical researchers and clinicians. NASA has made significant
contributions to the field of patient monitoring. The requirements for
closely monitoring numerous physiological functions of the astronauts
has resulted in many valuable innovations that have been and can be
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used to improve the monitoring of patients. This report describes
many of the NASA contributions to cardiovascular monitoring. In
addition, two innovations in intracardiac blood pressure monitoring
are discussed in greater depth. The chart on the following page
indicates the structure of the report from the general area of patient
monitoring down to the detail of cardiac catheter blood pressure
transducers.
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CARDIOVASCULAR MONITORING
The condition of the cardiovascular system is of vital importance. If
the flow of blood is stopped, the body will rapidly deteriorate and
irreparable brain damage will occur within only four minutes. For
these reasons it is extremely important to closely observe a patient
whose circulatory system is damaged or weakened. Observation of
pulse rate and blood pressure every few minutes is insufficient for a
patient in critical condition; these and other parameters must be
monitored continuously. The most feasible solution is the use of
electronic equipment which can immediately alert a nurse or physician
in case of a significant change in heart function. Rapid detection of coronary
malfunctions can be the key to saving the lives of many cardiac patients.
Electronic equipment is used to monitor the heart in non-critical
situations as •well. The electrocardiogram has been used for years to .
assist physicians in diagnosing heart damage. This type of testing is
sometimes called diagnostic monitoring and is used to detect heart
damage or irregularities before they become a serious hazard to the
patient's health.
In addition to pulse rate and blood pressure, important parameters
for cardiovascular monitoring are: electrical signals generated by heart
muscles, cardiac output, intracardiac blood pressure, heart sounds,
blood flow, and oxygen saturation. New and improved monitoring equip-
ment for detection of these heart functions is constantly being developed.
Electrocardiography (EKG)
One of the most important and well-established methods of monitoring
the heart is the technique of recording the heart's electrical activity.
The electrocardiogram, as the record is called, can be used to detect
heart damage or defects. To perform this task it is necessary to attach
electrodes to the chest of the patient. Attaching the electrodes can be
time consuming and irritating to the patient because it may involve
shaving, cleaning, and abrading the skin to produce good contact, apply-
ing irritating electrode jellies and finally gluing on the electrode. Metal
electrodes can irritate the skin because of their rigidity, and may be
so thick that the patient cannot comfortably lie on them. Most types of
electrodes rarely remain securely fastened for more than a day and a
half; if the patient does not remain stationary, this time may be further
reduced.
Because of the NASA requirement of monitoring the astronaut's EKG
waveform, a large variety of electrodes and pastes of advanced quality
have been designed. Many types of electrodes were developed at the
Manned Spacecraft Center for the purpose of long-term monitoring
without irritation or loss of contact. One type of electrode has remained
in use for a period of fourteen days during which the subject participated
in normal activity. Another electrode has been designed which requires
only decreasing of the skin -- an inexpensive and disposable model which
saves the time normally spent in cleaning the electrodes for future use.
The well-known spray-on electrodes were developed as a result of a
requirement at the NASA Flight Research Center. In order to perform
routine monitoring of test pilots, it was necessary to instrument and
check out a pilot in less than three minutes. The outcome was a product
which could be used to apply a single electrode in 20 seconds. This
has been useful for two separate non-NASA applications. First, the
spray-on electrodes are valuable for use in EKG clinical screening
because they can be applied quickly and removed easily without skin
irritation. The electrodes maintain excellent contact for several hours
even under active conditions, and can be used by physicians to obtain
EKG's from a patient undergoing exercise. The technique of monitoring
a patient's EKG during exercise may prove to be very important in detect-
ing heart defects before they become serious.
Secondly, the spray-on electrodes have proved essential for ambulance
EKG transmission systems because they may be applied rapidly and
reliably even under emergency conditions. The ability of a physician
to examine a patient's EKG immediately after a heart attack is extremely
important for proper diagnosis and treatment. The transmission system
will be discussed in more detail further on in this section.
More recently, flexible electrodes have been developed for extended space
mission requirements during which a soft, body conforming, flexible
electrode would be valuable. The electrodes consist of silicone rubber
loaded with silver-plated particles, which can be molded or cut to fit
comfortably over irregular body contours and move with the skin,causing
far less irritation than normal electrodes. Because of the comfort of
the electrodes, they have excellent possibilities for long-term patient
monitoring, especially for infants on whom currently available electrodes
are quite large and uncomfortable. In addition to the electrodes, flexible
wires have been used as connectors which are comfortable and less likely
to break from body movement.
NASA has funded work on a contourograph display system for presentation
of EKG data. Contourography is a technique for presenting repetitive
analog signals in a highly informative manner. Using this technique,
each cycle of a semi-periodic signal is displayed on one of a series
of separate horizontal baselines. A major change in the signal stands
out from the regular pattern. The EKG may be displayed using the
contourography format with the result that each heart beat appears as
a series of waveforms. By observing the contourograph, a physician
can quickly detect heart irregularities or arrhythmias. The contourograph
developed previously by Webb did not display the EKG waveform in its
accepted time sequence and the contourogram was generated on a
photographic film strip, resulting in a delay for the physician. NASA's .
device displays the waveform in the correct sequence by using an
improved triggering scheme. The waveform is shown on a variable
persistance CRT, thus supplying the physician with a real time
display of EKG signals.
More than 60% of the deaths from heart attacks occur within an hour
after the onset of the attack. Normally the time a patient spends in
an ambulance cannot be used for diagnosis or treatment; however, -with
a system developed as a result of NASA work, it is possible to transmit
a patient's EKG from the ambulance to the hospital. This would assist
a physician at the hospital in diagnosing a patient before the ambulance
has arrived and might even allow the doctor to instruct the ambulance
attendant to perform critical treatment. NASA was the pioneer in
developing the ambulance EKG transmission system. Use of the spray-
on electrodes allows the patient to be connected to the monitor very
quickly.
Cardiac Output
NASA has funded work on a four electrode impedance plethysmographic
system for monitoring ventricular stroke volume or cardiac output.
This device has tremendous potential for clinical use and has already
been used to monitor heart transplant patients during the postoperative
follow-up period. The system allows a physician to closely monitor the
volume of blood passing through the heart without the need for surgically
implanted electrodes or transducers. The NASA work resulted in the
following improvements:
(1) Only a single channel recording is needed instead
of two,
(2) The errors introduced in estimating ventricular
ejection time from obscured heart sounds are
reduced by the new method of ventricular
ejection time detection,
(3) Further reduction in error is achieved by the
elimination of the graphical slope extrapolation
method and use of the peak magnitude of the
rate of change of impedance, and
(4) More comfortable electrodes are available.
The importance of this device is that the failing transplanted heart can
be detected at an early stage by monitoring the stroke volume analog.
Incipient rejection is indicated by a progressive reduction in stroke
volume. Thus, corrective action may be taken before it is too late.
At the Ames Research Center an implantable miniature ultrasonic
sonmicrometer has been developed and used to measure the dimensions
of the left ventricle and the changes in dimension during a heart beat.
The device uses the echoes of high frequency sound waves bounced off
the front and rear walls of the-heart to electronically determine the
heart dimensions. The implantable device has proved feasible, and
work on a transcutaneous sonocardiometer is under initial development.
The sonocardiometer would be strapped to an astronaut to monitor his
cardiac functions and to assess the effects of weightlessness and
acceleration. For a patient with heart trouble, this device will be able
to provide the means for determining the volume of blood ejected from
the heart at each beat, the presence of backward flow indicating valve
leakage, and the heart size. Present techniques require catheterization
of the heart for which the patient must remain in the hospital.
Phonocardiography
Phonocardiography is the process of obtaining and recording the sounds
produced by the heart. This technique provides information different
from EKG tests and presents the physician with additional data in the
diagnosis of cardiac defects. A microphone has been developed for the
detection of the heart sounds. This microphone has a better frequency
response as a result of shifting the resonance peak outside the frequency
band of interest (20-2,000 Hz). It is small in size and readily adaptable
to mass production techniques.
In addition, NASA is developing a heart sound preprocessor •which
employs methods that give the signal the following advantages:
(1) It is easier to program for computer analysis
and requires far less computer storage,
(2) It can be transmitted by standard FM techniques
used for other medical signals, and
(3) It is easier to relate to the audible sounds a
physician is accustomed to hearing.
The result will be a preprocessor which will enhance theephysician's
ability to use phonocardiography in detecting heart defects.
Vibrocardiography
Vibrocardiography is the detection of the acceleration of the chest wall
resulting from the movement of the heart during the cardiac cycle. It
has been shown that the accelerations are strongly related to the stages
of contraction, ejection, systole and diastole and that Vibrocardiography
may produce a record of these as accurately as the method of cardiac
catheterization. In order to detect the extremely small accelerations
involved, it is necessary to use a very sensitive transducer. NASA
has funded the development of a transducer which has excellent frequency
response (1.6 to 3,000 Hz, +_ 3db), and a dynamic range of 90 db. This
instrument will provide the physician with highly accurate and detailed
vibrocardiogram recordings.
Cardio tachometer
A cardiotachometer is a device which monitors and displays heart rate.
It is used for a patient in an intensive care unit or during surgery and
and might even be used to monitor a subject undergoing cardiovascular
stress analysis. A cardiotachometer with linear beat-to-beat frequency
response has been designed by NASA. It has a linear response over
the range of 30 to 270 beats per minute and an accuracy of + beat per
minute. It is capable of continuously displaying the heart rate with a
beat-to-beat indication of rate change rather than an averaged rate
change. Previous devices required 15 to 20 seconds to register a
change from 60 to 120 beats per minute. In critical situations, this
delay may not be tolerable.
Cardiac R-Wave Detection
In order to coordinate a heart assist device with the action of a failing
heart, it is necessary to obtain a reliable electrical signal that occurs
naturally during the heart's systolic contraction. The R-wave portion
of the pronounced QRS complex that occurs at the beginning of the heart's
pumping cycle can be used to control a heart-assist pump. Previous
R-wave detectors have not been totally satisfactory because they
occasionally miss pulses or falsely trigger with resulting erratic
pumping. A detector developed by NASA has been found to be extremely
reliable and accurate. It has been used in conjunction with a NASA
artifical heart controller^
Cardiac Blood Pressure Measurement
In intensive care units or during heart surgery it is frequently necessary
to monitor the pressure -within a patient's heart. A commonly accepted
procedure is to insert a catheter through a vein and into the heart. The
catheter may either be filled with a fluid and have a transducer at the end
(external to the patient's body) to sense the pressure changes transmitted
by the fluid, or the catheter may have a transducer at the tip which is
inserted into the heart. Catheters with tip transducers are potentially
superior because they sense the pressure directly. However, the tip
transducers available are relatively large in size, increasing the
chances of damage or obstruction to the vein. NASA has been responsible
for the development of two different types of transducers for the use
on tips of catheters. They are much smaller in size than any presently
manufactured ( .04 and .02 inches instead of the commercially available
.08 inches). In addition, they have better frequency responses which are
valuable in obtaining accurate pulse wave forms and possess lower
power requirements. The result is that the transducers are highly safe,
reliable, and capable of accurately detecting the pulse wave form.
Indirect Blood Pressure Measurement
Blood pressure measurement is probably the diagnostic technique most
frequently used by physicians today. The standard instrument is called
a sphygmomanometer, and must be used by an experienced nurse or
doctor. NASA has been extensively involved in blood pressure monitoring.
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One of the earliest devices was an automatic sphygmomanometer, used
on the Mercury and Gemini flights. It consisted of an automatically
inflating occluding cuff with gas pressure source, gas pressure regulator
and valve, transducer for cuff pressure, and a microphone to detect the
Korotkoff sounds. The device has been used clinically and was found to
be more accurate than the standard manual clinical method.
Another technique employs a transducer as a direct force balance probe
to detect the force required to restrain arterial deflection. Although the
technique has not been perfected, its feasibility has been demonstrated.
A second type of transducer has been developed for placement on the ear.
The device uses a cyclic-occlusion of the ear pina combined with measure-
ment of variations in the opacity of the ear capillary bed to detect blood
pressure. The system has been tested and found to be more accurate than
the standard method of pressure measurement.
A technique for rapid venous pressure measurement is being investigated.
Normally, quantitative venous pressure measurement requires direct
entry into a vein. This new method requires only that a patient exhale
through a constricted orifice, which causes the pressure to rise in his
lungs and the surrounding area including the heart. The pressure measured
orally is equal to the venous pressure at heart level. If the oral pressure
is increased enough, the blood flow toward the heart in a vein in the arm
will cease when the arm is at heart level and the oral pressure is equal
to or greater than the venous pressure. A transcutaneous doppler blood
flow sensor is used to detect the flow cessation. This method may be of
significant value to the clinician in providing rapid non-invasive venous
pressure measurement.
Blood Flow
NASA has been funding the development of non-invasive ultrasonic
techniques for study of peripheral arterial and venous blood flow. The
instruments inject high frequency sound into an artery or vein and detect
the phase shift that occurs in the sound which is reflected off of particles
in the blood in order to determine the blood's velocity. Electromagnetic
flowmeters have been developed by other researchers but they produce
only an averaged flow velocity. Prior to NASA research the only ultra-
sonic flowmeters available gave only qualitative information on flow
velocity.
NASA funding has resulted in two innovations. The first was the develop-
ment of a continuous wave doppler flowmeter capable of sensing direction
of flow. The blood reverses direction of flow in the arteries even in normal
subjects. Detection of the reversal is advantageous in diagnosing a number
of vascular diseases such as arteriovenous fistula, aortic regurgitation,
or arteriosclerosis obliterans. Although other directional flowmeters
are now available, the first clinically useable one was developed by a
NASA researcher.
The second innovation has been the development of a pulsed doppler
ultrasonic flowmeter. This device can not only detect the direction of
11
flow, but is also capable of determining the cross sectional flow profile
in an artery or vein as well as the internal diameter of the artery or
vein. Again the NASA researcher developed the f irst clinically useable
instrument in this country, if not the entire world. Although refinements
are needed, the techniques have demonstrated their feasibility and value.
The pulsed doppler is capable of producing considerably more information
on the condition of the arteries or veins by indicating the location and
nature of turbulent blood flow.
The goal of physicians is to obtain a device that can be used to screen
patients for the early detection of circulatory diseases. This technique
would be extremely valuable in treating a patient before he developed a
serious incurable disease. One physician is already using the NASA
device to detect (in addition to the diseases already mentioned): throm-
bophlebitis, occlusion of the internal carotid artery, thoracic outlet
syndrome, accurate venous or low blood pressures, condition of arterial
grafts, and the condition of a vein or artery during and after catheterization.
In summary, the NASA-developed ultrasonic blood flowmeters show great
promise for the future of research and diagnosis of peripheral vascular
diseases.
Blood Oxygen Saturation
It is frequently necessary to determine the oxygen saturation in a patient's
blood because it is an important indicator of his condition. NASA has
sponsored the development of an oximeter which is used on the ear to
detect the oxygen content in the blood. The saturation is measured by
detecting the percentage of oxygenated hemoglobin in the blood with a
photoelectric photometer. Oxygenated and reduced hemoglobin absorb
different amounts of light of wavelength 640 millimicrons, but they
absorb the same amount of light of wavelength 800 millimicrons. The
device therefore uses the difference between the absorption levels to
determine the oxygen saturation.
This instrument could be used to monitor a patient during surgery or
in an intensive care unit. Continuous measurement could prove invaluable
to patients in critical condition.
Cardiovascular Stress Analysis
This is a rapidly growing area of interest among physicians who feel
it is important to observe the effect that controlled exercise or stress
has upon the cardiovascular system. Stress can reveal a great deal of
information about a patient's condition that normal testing cannot show.
In addition to the monitoring techniques already discussed, NASA has
developed equipment which can be used to measure a controlled amount
of stress on a patient. A bicycle-like device called an ergometer has
been devised and calibrated in order to monitor the amount of work a
patient is performing. In addition, the calibrator makes accurate
calibration of any type of ergometer possible so that work rate can be
determined and recorded. Therefore the work rate may be duplicated
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and the effect of exercise may be determined on different ergometers
at various locations and under different conditions. Initially developed
for studying the effects of weightlessness of astronauts, the ergometer
and calibrator show promise as valuable tools for future research and
diagnosis of cardiopulmonary diseases.
Another instrument called the lower body negative pressure device
was originally designed to test the effect of a weightless condition on
the cardiovascular system of an astronaut in space. By subjecting the
astronaut's legs and lower body to a partial vacuum, the effect of pooling
of the blood in the legs that occurs under gravity is simulated. Regular
use by the astronauts may help keep the leg muscles in tone and save
them from blood pooling and the resulting fainting spells when they
return to earth after a long mission. This device could also be used
on a subject to induce a controlled stress, enabling a physician to
assess the state of his cardiovascular system. Monitoring a patient's
reaction under stress will give early indications of defects that normal
testing under rest conditions cannot provide.
In summary, NASA has been responsible for the development of equipment
to monitor a large number of cardiovascular parameters: electro-
cardiographic signals, ventricular stroke volume, heart size, phono-
cardiographic and vibrocardiographic signals, heart rate, cardiac blood
pressure, arterial blood pressure, venous blood pressure, blood flow
velocity and volume in arteries and veins, diameter of arteries and
veins, and oxygen saturation. Several devices such as the spray-on
electrodes, ambulance EKG transmitter, impedance plethysmograph
and the R-wave detector have already been used and found to be extremely
valuable. Fortunately, NASA is continuing its pioneering work in car-
diovascular monitoring and we can look forward to such developments as
improved cardiac catheters and the use of ultrasonics in the detection of
cardiovascular disease.
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CARDIAC CATHETER BLOOD PRESSURE TRANSDUCERS:
NASA CONTRIBUTIONS
Cardiac catheters have been used to determine blood pressure within
the heart for approximately 30 years. NASA has developed transducers
for pressure measurement which are highly sophisticated and compare
favorably with products commercially available. Their small diameters
make chem safe to use on small arteries and veins, their low voltage
requirements decrease the chance of shock, and their frequency character-
istics enable them to produce very accurate pressure waveforms. It
should be emphasized that NASA did not fund work on these devices for
the purpose of developing transducers for blood pressure measurement.
Rather, these devices were originally designed for use in wind tunnels
and other aerospace research; their application to blood pressure
measurement is a direct spin-off resulting from NASA research.
NASA has funded the development of two separate pressure transducers,
one at the Ames Research Center and one at the Electronics Research
Center (ERC)*. These devices were clearly superior to commercially
available instruments at the time they were developed. Both devices
are presently undergoing initial production and are in competition with
the other transducers marketed. Historically, many of the leading
transducer products which have been commercially available were those
manufactured by Statham Instruments, Inc. Although there have been
many other companies engaged in production, Statham appears to have
led the field since the beginning. Consequently, primarily Statham products
have been used as the guidelines for comparison. This decision was
made on the basis of other known available products and recommendations
by users.
The Use of Cardiac Catheter Blood Pressure Transducers
It is frequently important to monitor the blood pressure directly within
the heart to obtain information on its condition. Direct measurement
within a vein or artery may be insufficient because the pulse wave
is altered considerably in travelling from the heart. The necessity
for monitoring the pressure may arise as a clinical test, in the operating
room during surgery, in the post-operative recovery room, or in
coronary or intensive care units. Monitoring assists the physician in
determining the state of cardiovascular defects, damage, or recovery.
The process of performing blood pressure measurements within the
heart is called cardiac catheterization. The most common type is
right heart catheterization which involves the insertion of the catheter
into an antecubital or femoral vein. After insertion, the catheter is
*
The Electronics Research Center has been terminated by NASA and
the facilities are now used by the Transportation Systems Center of
the Department of Transportation.
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advanced through the vein into the superior vena cava and the right
atrium. It may then be manipulated into the right ventricle and
pulmonary artery, into the inferior vena cava, or into the coronary
sinus. The catheter may be left inserted from a matter of minutes
to as long as a week.
Left heart catheterization is performed less frequently because it
normally requires that the wall of the heart be punctured. This is a
more difficult procedure and involves substantially more risk for the
patient.
There are basically two types of catheter systems for cardiac blood
pressure measurement. The first type is a fluid-filled tube that has a
thin membrane at the tip which is inserted into the heart during use. On
the opposite end of the tube there is a transducer -which remains external
to the patient's body. The pressure changes in the heart are transmitted
through the membrane and fluid to the transducer. The second type
of system is a catheter tip transducer. In this case a very small trans-
ducer is situated on the tip of the catheter. The catheter itself consists
of current carrying •wires that are covered within a thin layer of plastic.
The catheter tip transducers are potentially capable of more accurate
measurements because the pressure is sensed directly at the transducer
rather than at the end of a fluid-filled column. In recent years, several
miniature tip transducers have become commercially available. However,
a vast majority of the catheter-transducer systems in use are of the first
variety, a catheter with an external transducer. This particular device
has found -wide acceptance with hospitals and physicians because they
prefer equipment which has been proven effective over time. This is
evidenced by the fact that one basic transducer introduced to the market
eight to ten years ago still enjoys considerable use.
Although the fluid-filled catheters are satisfactory, there is much room
for improvement. Intracardiac blood pressure is composed of:
(1) variations of low frequency and high amplitude
which constitute the normally recorded pressure
curves, and
(2) variations of high frequency and low amplitude.
They constitute the sounds and murmurs that
modulate the pressure curves. The sounds can
reach frequencies of 10 KHz and cannot be trans-
mitted through the fluid-filled catheters without
considerable attenuation. Catheter tip transducers
have the advantage that they can pick up the high
frequency sounds. Most such transducers detect
frequencies up to I or 2 KHz, whereas the fluid-
filled systems can only monitor up to about 50-60
Hz.
The high frequency sounds are those recorded in phonocardiograms. The
phonocardiogram is usually made by placing a microphone on the chest
above the heart; the detected sounds being used to diagnose heart problems.
A high frequency response catheter tip transducer has the potential to
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produce far better phonocardiograms because the sound does not have to
travel through the chest. In addition, the transducer may be manipulated
to pinpoint the location of a defect and then by using x-rays its exact
position in the heart may be specified. The tip transducer may, therefore,
be used to diagnose many heart diseases or defects which the fluid-
filled catheter cannot. Some of these diseases are: small patent
ductus arteriosus, pure mitral stenosis, interventricular septal defect,
mitral valve disease, moderate mitral stenosis, slight mitral regurgitation,
moderate valvular aortic stenosis, variations of a systolic murmur
of mitral insufficiency in the left atrium, aortic insufficiency associated
with the valvular aortic stenosis, valvular aortic stenosis associated with
mitral stenosis, and subvalvular aortic stenosis-diaphragmatic type and
muscular type. It must be noted that catheterization involves higher
risks and cost than a standard phonocardiogram and would not normally
be used. However, in cases where catheterization is required, the
ability to obtain a phonocardiogram -with a catheter tip transducer may
greatly enhance the physician's ability to diagnose.
Another disadvantage of the fluid-filled catheter is that there is a delay
between the heart beat and the transducer detection because of the fluid
medium, making it difficult to coordinate the pressure waves with the
EKG signals.
One final disadvantage of the fluid-filled catheters is that they are highly
subject to motion artifact such as patient movement. Occasionally even
the contractions of the heart itself will introduce noise into the transducer.
Most hospitals perform cardiac catheterization on a routine basis. It
is a very important technique for monitoring the condition of a patient's
heart. In addition to the frequency response and other factors affecting
the accurate representation of the pulse wave form, doctors are concerned
about the risk involved in catheterization. One major concern is the
possibility of electrical shock to the patient. If the electronic equipment
short circuits and delivers a shock to the patient through the tip of the
catheter in his heart, the result could be fatal. A current as low as 100
microamperes travelling through the heart can cause ventricular fibrilla-
tion. Consequently, decreasing the chance of shock is extremely important.
One other factor that must be considered is the size of the catheter (or tip
transducer). Use of a large catheter can obstruct a vein or cause venospasm.
This is a particular problem in infants because of the small size of their
veins. If a fluid-filled catheter is used, then a tradeoff must be made
because smaller catheters produce lower frequency responses.
NASA Contributions
NASA researchers have developed two different types of transducers which
are being used as catheter tip transducers. The table on page 18 contains
the specifications on all of the transducers. The following are brief
definitions of the parameters:
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Diameter. Diameter of catheter tip (smaller tips
are better).
Resolution. The smallest change in pressure that
can be measured - (smaller is better).
Natural Frequency. The frequency at which the
transducer has peak amplitude out/amplitude in
(higher is better).
Frequency Response. The number given is the high-
est frequency the transducer can reasonably
reproduce (higher is better).
Non-Linearity and Hysteresis. Closeness of
calibration curve to a specified straight line
(smaller is better).
Thermal Zero Shift. Change in output due to
temperature effects only (smaller is better).
Rated Excitation Voltage. Voltage supplied to
transducer (smaller is better).
Pressure Range. Range of pressures for which
non-linearity specification holds true (larger
range may be an asset depending on usage).
Maximum Allowable Pressure. The largest pressure
the transducer can withstand without damage
(larger is better).
Information that is not available from the manufacturers is marked on
the table as "no specs. "
The f irst NASA transducer was a capacitance diaphragm-type developed
at Ames Research Center as a result of requirements for wind tunnel
testing. At the time of development, this tip transducer was smaller
in diameter than any others available (.04 instead of .065 inches). It
also had a higher frequency response (somewhere between 2 and 10 KHz
instead of 2 KHz) and a smaller power requirement (4 volts instead of
7. 5 volts) than the commercial product. The Ames transducer is superior
to the Statham P866 in all but thermal zero shift and maximum allowable
pressure. However, these two differences are really minor since
the thermal zero shift is actually quite small and a maximum pressure
of 600 mm Hg is really sufficient. The size of the Ames transducer
will enable it to be used without fear of venous damage, even on infants.
Its high frequency response will produce accurate pressure waves and
allow it to be used for phonocardiography, and its smaller power require-
ments make it potentially safer.
A miniature electromechanical tunnel diode transducer developed at
ERC has also been used as a catheter tip transducer. Its specifications
are even more impressive than those of the Ames transducer. It is only
.02 inches in diameter, one third the size of the smallest commercially
available device. Its frequency response (greater than 5,000, possibly
as high as 100,000) is much greater than the response of any other tip
17
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transducer. These two factors, size and frequency response, will
probably make this transducer extremely valuable for phonocardiography
because it can detect such high frequency murmurs with such pinpoint
type accuracy. There is no other instrument available which can begin to
compare with this transducer.
Most impressive of all, however, are the minute power requirements for
the ERC transducer. It uses less than . 1 volts, l/40th of the amount of
the Ames transducer. This fact -will make the ERG instrument extremely
safe because the electronic circuitry will not be capable of producing
nearly as large a shock as the normal transducer circuitry.
The fine resolution should be noted also, but it is difficult to evaluate
because the resolution was unknown on all but one other transducer.
The non-linearity and hysteresis may seem somewhat large. However,
the value given is the upper bound; an accurate determination had not
been made at the time of this report.
As shown in the table, the ERC transducer has resulted in two slightly
different transducers, one for arterial pressure and one for venous pressure
measurement. The devices are basically the same and differ only in the
pressure range used, resolution, thermal zero shift, and maximum
allowable pressure.
The standard Device Research models, TD-1 and TD-2-V, are both made
with a diameter of .05 inches at a price substantially lower than the
cost of the competitive products. However, upon request, both transducers
can be built with a . 02 inch diameter at a total cost no higher than that
of the other commercially available products.
The diameter, frequency response, and rated excitation voltage are
plotted in the three graphical displays. These displays indicate the effect
NASA has had on the advancement of cardiac catheter tip transducers.
The horizontal axis represents the time span in years from 1955 to 1971.
The vertical axis represents diameter, frequency response, and rated
excitation voltage, respectively, for the three displays. These three
parameters are plotted for each of the six basic transducers given in the
table. (The TD-1 and TD-2-V are plotted as the same points.) For the
transducers which have their frequency response given as a range in the
table, the frequency response is plotted as a line rather than a point on
the display. In addition to the points which have been plotted according
to the table, the graphs also contain points indicating the year that the
NASA innovation occurred. For example, on the diameter display, the
ERC transducer is plotted at .02 inches in 1971 as the date of commer-
cialization and at .02 inches and 1969 as the date of innovation. The
distance between the two points indicates the time lag between invention
of the device and its commercial availability.
For the Ames transducer, the time is about three years; for the ERC
transducer -- slightly more than one year. The reason for this discrepancy
is that there have been production problems with the Ames device, where-
as the ERC transducer appears to be advancing quite smoothly.
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In summary, NASA has made two very impressive contributions to
instrumentation for intracardiac blood pressure monitoring. The trans-
ducers have significantly advanced the state-of-the-art, especially
the instrument developed at ERC which is a substantial innovation.
Cardiac catheterization is a very common and important method of
monitoring in hospitals. Increased safety and precision are improvements
that are vital to the heallh of every patient who undergoes catheterization.
It is difficult to estimate the exact benefit, but lives may be paved as a
result of the NASA contributions.
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TECHNOLOGY TRANSFER IN PATIENT MONITORING
The purpose of this section is to present a brief overview of the process
of NASA technology transfer as it relates to patient monitoring. A
transfer is defined as the adoption of a NASA technique or instrument
to solve a non-NASA problem. There are several ways in which a
transfer may occur. First, a firm contracted by NASA to design and
construct a piece of equipment may later acquire a license to produce
it commercially. A second type of transfer occurs when an individual
or manufacturer learns of a device through a journal or other literature
and inquires about using it or obtaining a license to produce it. In
addition, NASA has endeavored to take an active role in the implemen-
tation of transfers. The Technology Utilization Division (TUD) was
formed specifically to assist in expeditiously transferring NASA tech-
nology to the scientific and industrial community. TUD has engaged in
an extensive publications program in order to disseminate information.
In the area of biology and medicine, TUD has also established three
Biomedical Application Teams whose purpose is to actively engage in
the process of technology transfer. These teams are located at the
Midwest Research Institute, Research Triangle Institute and Southwest
Research Institute. The team members communicate with researchers
and clinicians at medical institutions to directly assist in solving biol-
ogical and medical problems.
The Technology Utilization Division publishes Tech Briefs which announce
new technology developed under the space program. The Briefs are
circulated among thousands of subscribers. More than 70 Tech Briefs
have been published that relate directly to the area of patient monitoring.
There is usually a Technical Support Package available as backup material
for the Tech Brief, which can be obtained by contacting the NASA center
from which the Tech Brief originated. Well over 2, 500 TSP's have been
requested for the Briefs related to patient monitoring. More TSP's were
requested on biotelemetry equipment than on any other group. This
phenomenon can be explained by the fact that NASA has developed
extremely sophisticated telemetry systems as a result of the require-
ments for remote communications and monitoring. However, if only
physiological functions are considered, by far the most TSP's were
requested in the area of cardiovascular monitoring and analysis. This
large number of requests occurred for two reasons: f irst , there is an
urgent need to provide better cardiovascular monitoring of critically
ill patients and of patients undergoing clinical screening, and second,
NASA has done a great deal of work on cardiovascular monitoring
because of the intense interest in understanding and monitoring cardio-
vascular functions of astronauts performing tasks under weightless
and other special conditions.
Questionnaires were sent by the Denver Research Institute to a sample
of the TSP requestors. The results of the questionnaires revealed that
approximately 50% of the requestors had made valuable use of the infor-
mation in the TSP. This is additional evidence that NASA technology
has benefited the biomedical community.
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Bioinstrumentation Tech Briefs and the Number of
Tech Brief
Number
Requestors for Technical Support Packages
Number of
Requestors
T e c h B r i e f T i t l e forTSP 's
I. CARDIOVASCULAR MONITORING AND ANALYSIS
B64-10025
B64-10258
B65-10010
B65-10142
B65-10143
B65-10320
B65-10325
B66-10049
B66-10088
B66-10118
B66-10154
B66-10649
B67-10239
B67-10475
B67-10598
B67-10669
B68-10144
B68-10220
B68-10233
B68-10563
B69-10598
Improved Electrode Gives High-Quality Biological
Recordings
Digital Cardiometer Computes and Displays Heart-
beat Rate
Inexpensive, Stable Circuit Measures Heart Rate
Auxiliary Circuit Enables Automatic Monitoring of
EKG's
Digital -Output Cardiotachometer Measures Rapid
Changes in Heartbeat Rate
Rugged Pressed Disk Electrode Has Low Contact
Potential
Direct Force-Measuring Transducer Used in Blood
Pressure Research
Improved Electrode Paste Provides Reliable
Measurement of Galvanic Skin Response
Gelatin- Coated Electrodes Allow Prolonged Bio-
electronic Measurements
Integral Skin Electrode for Electrocardiography is
Expendible
Phonocardiograph System Monitors Heart Sounds
Spray-On Electrodes Enable EGG Monitoring of
Physically Active Subjects
A Phonocardiogram Simulator
Blood Pressure Reprogramming Adapter Assists
Signal Recording
Cardiotachometer with Linear Beat-to-Beat Fre-
quency Response
Ultraminiature Manometer-Tipped Cardiac Catheter
Cardiac R-Wave Detector
New Electrical Impedance Plethysmograph Monitors
Cardiac Output
Electrocardiograph Transmitted by RF and Telephone
Links in Emergency Situations
Pressure-Sensitive Bonded Junction Transducers
Quick Don-Doff Electrode Pastes
11
8
10
4
4
4
2
4
7
7
29
93
89
3
111
151
55
65
54
7
16
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Number of
Tech Brief Requestors
Number T e c h B r i e f T i t l e for TSP's
B69-10690 Miniature Backward-Diode Pressure Sensor 0
Features Stability and Low Power Consumption
B70-10030 Contourograph Display System for Monitoring 8
Electrocardiograms
B70-10420 Ultra-Flexible Biomedical Electrodes and Wires 27
II. RESPIRATORY ANALYSIS TOTAL 769
B64-10259 Pneumotachometer Counts Respiration Rate of 7
Human Subject
B65-10369 Respiratory Transfer Valve Has Fail-Safe Feature 3
B68-10188 High- and Low-Pressure Pneumotachometers Measure 5
Respiration Rates Accurately in Adverse Environments
B68-10365 Automatic Patient Respiration Failure Detection Sys- 56
tern with Wireless Transmission
B68-10438 Nosepiece Respiration Monitor 15
B69-10319 Miniature Oxygen Resuscitator 5
B70-10402 Improved Photoionization Mass Spectrometer 0
B70-10528 Technique for Analyzing Human Respiratory Process 24
III. ELECTROENCEPHALOGRAPHY TOTAL 115
B66-10536 Helmet System Broadcasts Electroencephalograms of 129
Wearer
B70-10110 Electronic Sleep Analyzer 11
IV. CHEMICAL ANALYSIS TOTAL 140
B66-10515 Apparatus Enables Automatic Microanalysis of Body 45
Fluids
B67-10245 Automated Urinalysis Technique Determines Concen- 15
tration of Creatine and Creatinine by Colorimetry
V. VISION TESTING TOTAL 60
B68-10206 Infrared Viewing Would Permit Human Iris Response 17
Studies
B69-10444 Oculometer for Remote Tracking of Eye Movement 0
TOTAL 17
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Number of
Tech Brief Requestors
Number T e c h B r i e f T i t l e for TSP's
VI. TEMPERATURE TELEMETRY
B66-10057 Miniature Bioelectronic Device Accurately Measures 282
and Telemeters Temperature
TOTAL 282
VII. BONE DENSITY MEASURE
B68-10140 Instrumentation for Bone Density Measurement 7
TOTAL 7
VIII. DOSIMETRY
B66-10252 Semiconductor Forms Biomedical Radiation Probe 2
B68-10426 Ceric and Ferrous Dosimeters Show Precision for 0
50-5000 Rad Range
TOTAL 2
DC. BIOTELEMETRY
B64-10171 Subminiature Biotelemetry Unit Permits Remote Phy- 292
siological Investigations
B66-10624 Miniature Telemetry System Accurately Measures 157
Pressure
B68-10065 Multichannel Implantable Telemetry System 195
B69-10117 Remotely-Actuated Biomedical Switch 9
B69-10312 New Passive Telemetry System 11
B70-10079 Telemetry for Impact Acceleration Measurements 7
TOTAL 671
X. MISCELLANEOUS
B 63-1000 3 New Low-Level A-C Amplifier Provides Adjustable 10
Noise Cancellation and Automatic Temperature Com-
pensation
B65-10079 Photoelectric Sensor Output Controlled by Eyeball 20
Movements
B65-10091 Simulator Produces Physiological Waveforms 8
B65-10203 Tiny Biomedical Amplifier Combines High Perform- 177
ance, Low Power Drain
B66-10534 Miniature Piezoelectric Triaxial Accelerameter 40
Measures Cranial Accelerations
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Tech Brief
Numb e r
B66-10549
B67-10076
B67-10369
B67-10663
B68-10131
B68-10174
B69-10088
B69-10224
B69-10294
B69-10385
B69-10720
B70-10107
B70-10348
B70-10452
B70-10508
T e c h B r i e f T i t l e
Miniature Electrometer Preamplifier Effectively
Compensates for Input Capacitance
Cleanroom Air Sampler Counts, Categorizes, and
Records Particle Data
Number of
Requestors
for TSP's
105
115
4
50
Multiple Meter Monitoring Circuits Served by Single
Alarm
Review of Biological Mechanisms for Application to
Instrument Design
Automated Patient Monitoring System 51
Low Scatter Lightweight Fission Spectrometer Con- 0
structed for Biological Research
Microscopes and Computers Combined for Analysis 0
of Chromosomes
Two Devices for Analysis of Nystagmus 2
Mass Culture of Photobacteria to Obtain Luciferase 0
Improved Perceptual-Motor Performance Measure- 7
ment System
Biomedical Bulk Data Processing Program 0
Detection and Location of Metal Fragments in the 19
Human Body
Electromechanical Hand Incorporates Touch Sensors 4
and Trigger Function
Self Testing and Repairing Computer: A Concept 2
Log Amplifier Instrument Measures Physiological
Biopotentials Over Wide Dynamic Range
TOTAL 614
TOTAL OF ALL REQUESTORS 2677
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